2024 Market Report by Kings Research "Scaffold Technology Market Size, Share and Ranking, Overall Sales and Demand Forecast 2024-2031" provides an extensive examination of Scaffold Technology Market attributes, size assessments, and growth projections through segmentation, regional analyses, and country-specific insights, alongside a scrutiny of the competitive landscape, player market shares, and essential business strategies
Scaffold Technology Market Size was valued at USD 1,665.2 million in 2023 and is projected to grow from USD 1,889.3 million in 2024 to USD 5,142.4 million by 2031, exhibiting a CAGR of 15.38% during the forecast period.
Related Reports and Latest Industry Development News: https://www.kingsresearch.com/scaffold-technology-market-1784
Key Industry Developments:
Conmed's Acquisition of Biorez: In August 2022, Conmed acquired Biorez to expand its sports medicine soft tissue-healing portfolio
RevBio's NIH Grant: In June 2023, RevBio, Inc. secured a USD 2 million grant from the National Institutes of Health (NIH) for developing a new dental adhesive bone scaffold product.
Top News:
In March 2025:
Levee Medical received FDA approval to initiate the ARID II pivotal clinical trial under an Investigational Device Exemption (IDE) to evaluate the Voro Urologic Scaffold for the treatment of post-prostatectomy stress urinary incontinence. The randomized controlled study aims to assess the safety and effectiveness of the scaffold in men undergoing robotic-assisted radical prostatectomy.
Key Companies in Scaffold Technology Market:
- Arch Therapeutics
- ETS Tech Holdings
- Organogenesis
- Smith+Nephew
- BD
- Molecular Matrix
- PELOBIOTECH GmbH
- Vericel Corporation
- NuVasive
- Stryker
- PolyNovo Limited
- PolyMedics Innovations
- Acera Surgical
- Imbed Biosciences
- Anika Therapeutics
Market Dynamics and Key Drivers:
Hydrogels Lead the Market: Hydrogels accounted for the largest revenue share of 41.69% in 2022, owing to their favorable properties for cell loading and drug delivery.
Nanofiber-Based Scaffolds Show Rapid Growth: This segment is anticipated to witness the fastest CAGR of 14.56% from 2023 to 2030, driven by their applications in tissue engineering and regeneration.
Stem Cell Therapy and Regenerative Medicine Dominate Applications: These applications accounted for the largest market share of 66.45% in 2022, highlighting the extensive use of scaffold technology in these fields.
Contact us:
Kings Research
Website: https://www.kingsresearch.com
E-mail: business@kingsresearch.com
Phone: (+1) 888 328 2189
